Archive for the ‘korea retractions’ Category
The editors of an anesthesiology journal have retracted a paper about predicting how patients will respond to a procedure, after the results of an investigation cast doubt on the validity and originality of the work.
According to the retraction notice, the editors became concerned about the validity of the data and conducted an investigation, which found irregularities, “including misrepresentation of results.” Because the authors could not provide adequate evidence to assuage these concerns, the editors decided to retract the paper.
The paper — about which facial muscles best predict if a patient is ready to be intubated — had already been flagged on F1000: A few years ago, two anesthesiologists from Florida commented that they found the article “confusing,” and felt that the authors “did not prove their hypothesis.”
Here’s the retraction notice for “Comparison of four facial muscles, orbicularis oculi, corrugator supercilii, masseter or mylohyoid, as best predictor of good conditions for intubation: A randomised blinded trial,” published in the European Journal of Anaesthesiology in 2013 and cited once: Read the rest of this entry »
A researcher in South Korea has retracted a 2015 paper after telling the journal he falsified the institutional approval required to conduct the animal experiments.
In the article, the author explicitly says that the Animal Experiment Review Board of a university based in Seoul, South Korea approved the experiments, but according to the journal, “the author did not receive an approval by the board and he used a false approval number.”
Here’s the retraction notice for “The role of compensatory movements patterns in spontaneous recovery after stroke,” published in the Journal of Physical Therapy Science (JPTS) in September 2015 and retracted in December: Read the rest of this entry »
A researcher in South Korea has retracted a 2016 paper on which he is listed as senior author because a former student wrote and published the article without his permission.
According to the retraction notice, the former student also fabricated data and plagiarized “a substantial amount of material” from previous papers published by the senior and middle author.
Here’s the retraction notice for “Oleaginous yeast-based production of microbial oil from volatile fatty acids obtained by anaerobic digestion of red algae (Gelidium amansii),” published in the Korean Journal of Chemical Engineering in April 2016 and retracted in January: Read the rest of this entry »
The author of a high-profile book about the history of North Korea is issuing 52 corrections to the next edition, scheduled to appear this spring. The changes follow heavy criticism of the book, alleging it contained material not supported by the list of references.
Last month, author Charles Armstrong, a professor at Columbia University, announced on his website that he was issuing the changes after reviewing the book in detail, especially the footnotes. He writes:
If you think something is amiss with your data, running an experiment again to figure out what’s going on is a good move. But it’s not always possible.
A team of researchers in Seoul recently found themselves in a bind when they needed to check their work, but were out of a key substance: breast milk.
The shortage led them to the retract their 2016 paper on a micronutrient found in breast milk that helps protect infants’ retinas. “Association between lutein intake and lutein concentrations in human milk samples from lactating mothers in South Korea,” was published online last spring in the European Journal of Clinical Nutrition.
Here’s the retraction notice:
A new analysis of retractions from Korean journals reveals some interesting trends.
For one, the authors found most papers in Korean journals are retracted for duplication (57%), a higher rate than what’s been reported in other studies. The authors also deemed some retractions were “inappropriate” according to guidelines established by the Committee on Publication Ethics (COPE) — for instance, retracting the article another paper duplicated from, or pulling a paper when an erratum would have sufficed.
One sentence from “Characteristics of Retractions from Korean Medical Journals in the KoreaMed Database: A Bibliometric Analysis,” however, particularly struck us: Read the rest of this entry »
An award-winning account of North Korea during the Cold War has fallen under criticism, claiming the author included material not supported by the list of references.
One historian has uploaded a series of what he calls “noteworthy problems” with Tyranny of the Weak, winner of the John K. Fairbank Prize in East Asian History in 2014. Balazs Szalontai of Korea University primarily accuses author Charles Armstrong of citing either irrelevant or non-existent sources to support his claims.
The retraction notice for “Goodness-of-fit tests for a proportional odds model,” which appears in the Journal of the Korean Data and Information Science Society, cites an investigation by an academic ethics committee, but it’s unclear where this review panel was based.
With so many retraction notices pouring in, from time to time we compile a handful of straight-forward retractions.
Once again, this list focuses on duplications — but unlike other duplications, these authors were not at fault. Rather, these retractions occurred because the publishers mistakenly published the same paper twice — the result of a transfer between publishers, for instance, or accidentally publishing the unedited version of the paper. We’re forced to wonder, as we have before, whether saddling researchers’ CVs with a retraction is really the most fair way to handle these cases.
So without further ado, here’s five cases where the journal mistakenly duplicated a paper, and had to retract one version: Read the rest of this entry »
The paper explicitly noted that the authors do not have any financial conflicts of interest, and that a government program supported the study. According to the journal, a reader alerted them to the conflict of interest.
The cooperate tie wasn’t a secret, though — one of the authors was listed as affiliated with the company, Pharma Research Products, based in Korea.
Here’s the retraction notice for “A Phase III, Randomized, Double-Blind, Matched-Pairs, Active-Controlled Clinical Trial and Preclinical Animal Study to Compare the Durability, Efficacy and Safety between Polynucleotide Filler and Hyaluronic Acid Filler in the Correction of Crow’s Feet: A New Concept of Regenerative Filler:”